Positively Undervalued ASX Stocks in April 2025

2 min read | April 07, 2025 08:30 AM AEST | By Team Kalkine Media

Positively Undervalued ASX Stocks in April 2025 — Image source: Shutterstock

Capricorn Metals Ltd (ASX:CMM)

Capricorn Metals, with its focus on gold properties in Australia, operates primarily through the Karlawinda operations, generating revenue of A$379.47 million. Currently trading at A$8.47, Capricorn's valuation suggests it might be undervalued when its fair value estimate is A$11.54. The company shows promising revenue and earnings growth potential, supported by strong return on equity expectations in the near future.

Nanosonics Limited (ASX:NAN)

Renowned in the infection prevention arena globally, Nanosonics hits the radar with a trading price of A$4.64, compared to its estimated fair value of A$7.06. With sales growth to A$93.6 million and a positive net income trend, the firm projects faster growth than the general market, hinting at an exciting expansion horizon.

Sigma Healthcare Limited (ASX:SIG)

Sigma Healthcare, a major player in pharmaceutical wholesale and distribution in Australia, currently trades at A$2.89 against an estimated fair value of A$3.4. Despite some insider selling, the company's inclusion in prominent indices like S&P/ASX 100 underscores its market significance. Annual revenue projections point to significant growth beyond the market average, supported by strategic operations.

Disclaimer

The content, including but not limited to any articles, news, quotes, information, data, text, reports, ratings, opinions, images, photos, graphics, graphs, charts, animations and video (Content) is a service of Kalkine Media Pty Ltd (Kalkine Media, we or us), ACN 629 651 672 and is available for personal and non-commercial use only. The principal purpose of the Content is to educate and inform. The Content does not contain or imply any recommendation or opinion intended to influence your financial decisions and must not be relied upon by you as such. Some of the Content on this website may be sponsored/non-sponsored, as applicable, but is NOT a solicitation or recommendation to buy, sell or hold the stocks of the company(s) or engage in any investment activity under discussion. Kalkine Media is neither licensed nor qualified to provide investment advice through this platform. Users should make their own enquiries about any investments and Kalkine Media strongly suggests the users to seek advice from a financial adviser, stockbroker or other professional (including taxation and legal advice), as necessary. Kalkine Media hereby disclaims any and all the liabilities to any user for any direct, indirect, implied, punitive, special, incidental or other consequential damages arising from any use of the Content on this website, which is provided without warranties. The views expressed in the Content by the guests, if any, are their own and do not necessarily represent the views or opinions of Kalkine Media. Some of the images/music that may be used on this website are copyright to their respective owner(s). Kalkine Media does not claim ownership of any of the pictures displayed/music used on this website unless stated otherwise. The images/music that may be used on this website are taken from various sources on the internet, including paid subscriptions or are believed to be in public domain. We have used reasonable efforts to accredit the source wherever it was indicated as or found to be necessary.